G01N 2333/005
From viruses
Official title: from viruses
G01N2333/005 (From viruses) appears on 2,372 US grants and 4,141 published applications in this corpus.
Search patents in G01N- Granted patents
- 2,372
- Published applications
- 4,141
- Assignees
- 1,916
- Inventors
- 9,014
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 5 | 0 |
| 1992 | 8 | 0 |
| 1993 | 6 | 0 |
| 1994 | 9 | 0 |
| 1995 | 7 | 0 |
| 1996 | 17 | 0 |
| 1997 | 48 | 0 |
| 1998 | 60 | 0 |
| 1999 | 50 | 0 |
| 2000 | 44 | 0 |
| 2001 | 55 | 11 |
| 2002 | 37 | 44 |
| 2003 | 41 | 93 |
| 2004 | 39 | 84 |
| 2005 | 34 | 128 |
| 2006 | 41 | 113 |
| 2007 | 53 | 98 |
| 2008 | 54 | 96 |
| 2009 | 60 | 115 |
| 2010 | 62 | 168 |
| 2011 | 61 | 138 |
| 2012 | 52 | 122 |
| 2013 | 76 | 119 |
| 2014 | 89 | 126 |
| 2015 | 83 | 168 |
| 2016 | 97 | 182 |
| 2017 | 114 | 180 |
| 2018 | 152 | 186 |
| 2019 | 163 | 163 |
| 2020 | 126 | 158 |
| 2021 | 111 | 254 |
| 2022 | 103 | 289 |
| 2023 | 99 | 391 |
| 2024 | 113 | 332 |
| 2025 | 98 | 240 |
| 2026 | 101 | 143 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Binding protein specific for the spike protein of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2)6 Oct 2026US 12,754,184 B2Navigo Proteins GmbH
- HBV diagnostic, prognostic, and therapeutic methods and products6 Oct 2026US 12,754,185 B2Abbott Laboratories
- Quinine and its use to generate innate immune response29 Sep 2026US 12,746,236 B2The Trustees of the University of Pennsylvania
- Lassa virus-specific nanobodies and methods of their use29 Sep 2026US 12,747,284 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Anti-human immunodeficiency virus-1 antibodies and methods for uses thereof29 Sep 2026US 12,747,285 B2Grifols Diagnostic Solutions Inc.
- Prediction of immunostimulatory potential of aav in a human preclinical model8 Oct 2026US 2026/0309699 A1
- System and Method for Single Protein Detection by Digital Plasmonic Nanobubbles8 Oct 2026US 2026/0309704 A1Board of Regents, The University of Texas System
- Ace2 inhibition assay for evaluation of vaccine immunogenicity8 Oct 2026US 2026/0309709 A1Novavax, Inc.
- Identifying antibody virus-neutralization status8 Oct 2026US 2026/0309711 A1
- Tcr-mimic bispecific antibodies for hiv-11 Oct 2026US 2026/0297193 A1The Johns Hopkins University
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Nucleic acid multimers and amplified nucleic acid hybridization assays using same674US 5,124,246 AChiron Corporation · 1992
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Systematic evolution of ligands by exponential enrichment: chimeric selex281US 5,637,459 ANeXstar Pharmaceuticals, Inc. · 1997